Find information on thousands of medical conditions and prescription drugs.

Fraser syndrome

An autosomal recessive genetic disease, characterized by developmental defects including underdevelopment of the eyes (crytophthalmos) and the genitals (micropenis, cryptorchidism or clitoromegaly). Congenital malformations of the nose, ears,larynx, and renal system as well as mental retardation are manifest occasionally. The Fraser syndrom is also known as: Meyer-Schwickerath's syndrome, Fraser-Fran├žois syndrome, or Ullrich-Feichtiger syndrome.

The genetic background of this disease has been linked to a gene called FRAS1, which seems to be involved in skin epithelial morphogenesis during early development.

Fabry's disease
Factor V Leiden mutation
Factor VIII deficiency
Fallot tetralogy
Familial adenomatous...
Familial Mediterranean fever
Familial periodic paralysis
Familial polyposis
Fanconi syndrome
Fanconi's anemia
Farber's disease
Fatal familial insomnia
Fatty liver
Febrile seizure
Fibrodysplasia ossificans...
Fibrous dysplasia
Fissured tongue
Fitz-Hugh-Curtis syndrome
Flesh eating bacteria
Focal dystonia
Foix-Alajouanine syndrome
Follicular lymphoma
Fountain syndrome
Fragile X syndrome
Fraser syndrome
FRAXA syndrome
Friedreich's ataxia
Frontotemporal dementia
Fructose intolerance


[List your site here Free!]

Severe acute respiratory syndrome epidemic in Asia - Dispatches
From Emerging Infectious Diseases, 12/1/03 by Guofa Zhou

We analyzed the dynamics of cumulative severe acute respiratory syndrome (SARS) cases in Singapore, Hong Kong, and Beijing using the Richards model. The predicted total SARS incidence was close to the actual number of cases; the predicted cessation date was close to the lower limit of the 95% confidence internal.


As of May 15, 2003, the cumulative number of reported probable cases of severe acute respiratory syndrome (SARS) was [greater than or equal to] 7,600 worldwide (1). In the 28 countries reporting SARS cases, the People's Republic of China (PRC), particularly the Hong Kong Special Administrative Region and the Beijing Municipality, reported most of the cases. The Beijing municipal government took various measures to prevent the spread of SARS. As in Hong Kong (2,3), measures in Beijing included wearing masks and handwashing, mandatory home quarantine of persons who had contact with probable SARS patients, suspension of schools and universities for 2 weeks, restrictions on public gatherings, screening body temperatures of air travelers, discouragement of mass migration by air or train, designation of special hospitals for the treatment of SARS patients, and education on SARS transmission and personal protection. The number of new cases reported daily in Beijing were high (e.g., 39 new cases on May 14, 2003), and public and health authorities were concerned about how extensive the SARS epidemic might be and when the SARS epidemic might be brought under control if intervention measures were continued.

The Study

We examined the dynamics of reported SARS clinical cases in three cities in Asia (Beijing, Hong Kong, and Singapore) and used the Richards model (4) to predict SARS infection over several months. For Hong Kong and Singapore, data on SARS cases were extracted from daily reports of the World Health Organization (WHO) from March 17 to May 15, 2003 (1). For Beijing, the number of confirmed SARS cases was published by the Ministry of Health of PRC (5). (The PRC's report was used because WHO did not report SARS case incidence in Beijing; the WHO report summarized the total number of SARS cases in mainland China.) Although SARS case reporting started in early April 2003 in Beijing, the accuracy of SARS daily case reporting in Beijing before April 21 was questioned (16); thus our analysis for Beijing was based on case numbers from April 21 to May 15, 2003. Data indicated that daily new SARS cases were declining since April 12, April 2, and April 29 in Singapore, Hong Kong, and Beijing, respectively (Figure). The cumulative cases in all three localities resembled S-shaped curves (Figure).


When S(t) is used to represent the cumulative number of SARS cases on day t, the dynamics of S can be modeled as

dS/dt = r S/F(S),

where r is the intrinsic growth rate, and F(S) measures the effectiveness of intervention measures. The basic reproductive number of an infection, [R.sub.0] (defined as the average number of secondary cases generated by one primary case), can be estimated as [R.sub.0] = [e.sup.(rT)], where T is the generation time of an infection. This model assumes that 1) the rate of cumulative SARS case increase is proportional to the present number of cases, 2) without control measures the SARS case incidence grows exponentially, and 3) intervention measures will have a negative effect on SARS case increase. This model does not take into account spatial and stochastic processes of SARS transmission. F(S) can be expressed as

1/F(S) = 1 - [(S/K).sup.a],

where K is the maximum cumulative case incidence, and [alpha] measures the extent of deviation of S-shaped dynamics from the classic logistic growth model ([alpha] = 1). [alpha] > 1 or [alpha] < 1 indicates that the cumulative case numbers grow faster or slower than predicted by the logistic growth model (4). The explicit solution of the model is


and [S.sub.0] is the number of cases at t = 0. Parameter [t.sub.m] is the inflection point where maximum growth rate occurs; in the case of logistic growth model S = K/2 when t = [t.sub.m]. This model predicts that the cumulative SARS case incidence follows an S-shaped curve and gradually reaches a maximum case incidence, K. The end of the epidemic is defined as not a single new SARS case emerging in 3 consecutive months (7). The earliest time to reach this point, [t.sub.0], is calculated through the numerical solution of inequality



The association between cumulative number of cases and time is well described by the Richards model (Figure). For the three localities, highly significant correlations between observed and predicted incidence were found (adjusted [r.sup.2] > 0.98, p < 0.01 for goodness-of-fit of the model) (8). The maximum predicted cumulative incidence, K, was estimated to be 2,595 for Beijing, 1,748 for Hong Kong, and 207 for Singapore (Table). We estimated the 95% confidence interval (CI) of the predicted incidence and time for the epidemic to cease by inverse prediction based on the relationship Log ([(K/S).sup.a]-1) = r[t.sub.m]-rt (8). If we assume that an epidemic is over when no new cases occur in 3 consecutive months, the earliest time for the end of the SARS epidemic, if intervention measures continued and no cases were imported, was estimated to be June 27, 2003, in Beijing; June 29, 2003, in Hong Kong; and May 28, 2003, in Singapore (see Table for 95% CI). Using 8.4 days as the generation time of a SARS infection, as estimated from the mean serial interval between the time from onset of symptoms in index patient to onset of symptoms in secondary case-patient in Singapore (9), we estimated the basic reproductive number of SARS infections, [R.sub.0], to be 2.7, 2.1, and 3.8 in Singapore, Hong Kong, and Beijing, respectively. The higher [R.sub.0] value in Beijing likely resulted from delays in exercising effective control measures. The [R.sub.0] estimates for Singapore and Hong Kong, when the Richards model and SARS case incidence data through May 14, 2003 were used, were similar to those based on stochastic models (9,10).


The transmission mechanism of the coronavirus that causes SARS and the epidemiologic determinants of spread of the virus are poorly understood (2). Our predictions were based on the trend analysis, assuming effective intervention measures would continue in the three cities. Predicting SARS dynamics on the basis of data from early in the epidemic could have lead to untenable conclusions (11); however, we found that the SARS epidemic in Hong Kong and Singapore in May 2003, was not in an early stage. The case data in these two localities clearly indicated S-shaped dynamics. Assuming SARS dynamics in Beijing would follow a similar pattern, we used the Richards model to predict that the SARS epidemic in Beijing would end by late June 2003. This prediction, made on May 21, 2003, was based on the trend analysis and assumed that effective intervention measures would continue.

On May 30, June 23, and June 24, 2003, respectively, WHO removed Singapore, Hong Kong, and Beijing from the list of areas with local transmission (12-14). As of July 10, a total of 8,436 SARS cases had been reported in 29 countries worldwide (15). The actual cumulative SARS cases were 206 for Singapore; 1,755 for Hong Kong; and 2,631 for Beijing (5,15). The observed total SARS incidence was within our predicted 95% CI for all three localities (Table). The error rate (the difference between actual and predicted cumulative incidence divided by actual incidence) is 0.5%, 0.4%, and 1.4% for Singapore, Hong Kong, and Beijing, respectively.

The last probable SARS cases were reported on May 18 for Singapore, June 12 for Hong Kong, and June 11 for Beijing. The predicted SARS cessation date was later than the date the last probable SARS case was reported for all three cities but very close to the lower limit of the 95% CI (Table). Our results suggest that the simple Richards model describes well the SARS case incidence dynamics (under effective control measures) in Singapore, Hong Kong, and Beijing.


We thank three anonymous reviewers for their constructive criticism.


(1.) World Health Organization. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS) from: 1 Nov 2002 to: 15 May 2003, 18:00 GMT+2 [Accessed May 15, 2003] Available from: URL:

(2.) Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, et al. Epidemiological determinants if spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6.

(3.) Seto WH, Tsang D, Yung RWH, Ching TY, Ng TK, Ho M, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory, syndrome (SARS). Lancet 2003;361:1519-20.

(4.) Richards FJ. A flexible growth function for empirical use. J Exp Botany 1959;10:290-300.

(5.) Ministry of Health, People's Republic of China. http://www.moh.

(6.) Benitez MA. Beijing doctor alleges SARS cases cover-up in China. Lancet 2003;361:1357.

(7.) World Health Organization. WHO recommendations on SARS and blood safety. May 15, 2003 [Accessed July 17, 2003] Available from: URL:

(8.) Zar JH. Biostatistical analysis. 4th edition. Englewood Cliffs (NJ): Prentice Inc.; 1999. p. 324-59.

(9.) Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003;300:1966-70.

(10.) Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003;300:1961-6.

(11.) Razum O, Becher H, Kapaun A, Junghanss T. SARS, lay epidemiology, and fear. Lancet 2003;361:1739-40.

(12.) World Health Organization. Update 70-Singapore removed from list of areas with local SARS transmission. [Accessed July 17, 2003] Available from: URL: hnp:// 5_30a/en/

(13.) World Health Organization. Update 86--Hong Kong removed from list of areas with local transmission. [Accessed July 17, 2003] Available from: URL:

(14.) World Health Organization. Update 87--World Health Organization changes last remaining travel recommendation--for Beijing, China. [Accessed July 17, 2003] Available from: URL: http://www.

(15.) World Health Organization. Cumulative number of reported probable cases of SARS. [Accessed July 17, 2003] Available from: URL:

Guofa Zhou * and Guiyun Yan *

* State University of New York at Buffalo, Buffalo, New York, USA

Dr. Zhou is a senior research scientist at the State University of New York at Buffalo. His research interests are the ecology and epidemiology of infectious diseases.

Dr. Yan is an associate professor of biological sciences at SUNY Buffalo; his research focuses on the ecology and genetics of infectious diseases.

Address for correspondence: Guofa Zhou, Department of Biological Sciences, State University of New York at Buffalo, Buffalo, NY 14260, USA; fax: 716-645-2975; email:

COPYRIGHT 2003 U.S. National Center for Infectious Diseases
COPYRIGHT 2004 Gale Group

Return to Fraser syndrome
Home Contact Resources Exchange Links ebay